Hope springs eternal among policy makers in Europe’s beleaguered periphery. At five minutes to midnight in Athens, and with a bank run having started in Madrid, these policy makers cling to the forlorn hope that somehow Germany is going to relent on its strong opposition to euro bonds.

In case you missed it, AEI health expert Scott Gottlieb, MD explains the transformation of the pharmaceutical industry in a recently published piece (full text below). Drug discovery has become targeted, averse to bureaucracy, and focused on solving more difficult to cure, serious maladies.

Vance Fried explains what decision makers should know to rein in the cost of collage

The following is a letter to the editor in response to an April 8 op-ed in The Financial Times on the possibility of countries opting to leave the eurozone.

ABSTRACT

Using 1437 samples of Ciprofloxacin from 18 low-to-middle-income countries, we aim to understand the role that regulation and distribution channel have played in signaling and ensuring drug safety. According to the World Health Organization, some poor quality drugs are deliberately and fraudulently mislabeled with respect to identity or source while...

Using 1437 samples of Ciprofloxacin from 18 low-to-middle-income countries, we aim to understand the role that regulation and distribution channel have played in signaling and ensuring drug safety.

In an upcoming piece, AEI's Kevin Hassett highlights a new unique index of policy uncertainty which was developed in a path-breaking paper by Stanford economists Scott R. Baker and Nicholas Bloom along with AEI Visiting Scholar and University of Chicago economist Steve Davis. Among...

Government rebates on domesticcars would do less harm than a bailout of the Big Three automakers.